William Savage, MD, PhD
About William Savage, MD, PhD
Will Savage is the Chief Medical Officer with extensive experience in hematology and clinical development, having held significant positions at institutions like Harvard Medical School and Shire/Takeda.
Will Savage - Chief Medical Officer
Will Savage currently holds the position of Chief Medical Officer. In this role, he oversees the medical and clinical strategy of the organization, ensuring excellence in patient care and medical research. His responsibilities include guiding the development and implementation of clinical programs, maintaining regulatory compliance, and fostering innovation in medical treatment and diagnostics.
Will Savage Education and Expertise
Will Savage received his BA in Biochemistry magna cum laude from Columbia University. He went on to earn his MD with honors in research from Weill Cornell Medical College. Further enhancing his medical credentials, he obtained a PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. His extensive education provides a solid foundation for his roles in medical leadership and clinical research.
Will Savage's Professional Background
Will Savage began his medical career at Johns Hopkins University School of Medicine, where he trained in pediatric hematology/oncology and transfusion medicine. He served as an Assistant Professor of Pathology at Harvard Medical School and Brigham and Women's Hospital. His experience also includes roles as the Global Clinical Development Lead in Hematology at Shire/Takeda and Senior Medical Director at Magenta Therapeutics.
Will Savage at Magenta Therapeutics
Before becoming Chief Medical Officer, Will Savage was the Senior Medical Director at Magenta Therapeutics. In that role, he played a crucial part in directing clinical strategies and overseeing multiple therapeutic areas. His contributions helped advance the company's mission to transform transplant medicine.
Will Savage's Role at Shire/Takeda as Global Clinical Development Lead
Will Savage served as the Global Clinical Development Lead in Hematology at Shire/Takeda. His work focused on driving clinical projects and strategies within the hematology division, ensuring the development of innovative treatments. His contributions were instrumental in progressing clinical development and optimizing patient outcomes.